Quantbot Technologies LP Ironwood Pharmaceuticals Inc Transaction History

Quantbot Technologies LP

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$8.79 - $11.51 $545,859 - $714,771	-62,100 Reduced 89.35%	7,400 $84,000
Q3 2023 Nov 07, 2023	BUY	$8.25 - $11.35 $280,500 - $385,900	34,000 Added 95.77%	69,500 $669,000
Q2 2023 Aug 08, 2023	SELL	$10.1 - $11.6 $88,880 - $102,080	-8,800 Reduced 19.86%	35,500 $377,000
Q1 2023 May 12, 2023	BUY	$10.37 - $12.56 $459,390 - $556,408	44,300 New	44,300 $466,000
Q2 2022 Aug 09, 2022	SELL	$11.05 - $12.72 $75,007 - $86,343	-6,788 Reduced 78.13%	1,900 $21,000
Q1 2022 May 16, 2022	BUY	$10.61 - $12.88 $92,179 - $111,901	8,688 New	8,688 $109,000
Q3 2021 Nov 09, 2021	SELL	$11.92 - $13.92 $17,057 - $19,919	-1,431 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$10.16 - $13.11 $14,538 - $18,760	1,431 New	1,431 $18,000
Q4 2020 Feb 12, 2021	SELL	$9.05 - $12.2 $5,430 - $7,320	-600 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$8.99 - $10.74 $10,752 - $12,845	-1,196 Reduced 66.59%	600 $5,000
Q2 2020 Aug 13, 2020	BUY	$9.14 - $11.97 $14,953 - $19,582	1,636 Added 1022.5%	1,796 $18,000
Q1 2020 May 13, 2020	SELL	$8.58 - $14.01 $47,953 - $78,301	-5,589 Reduced 97.22%	160 $1,000
Q4 2019 Feb 10, 2020	SELL	$8.22 - $14.0 $4,529 - $7,714	-551 Reduced 8.75%	5,749 $76,000
Q3 2019 Nov 12, 2019	BUY	$8.59 - $10.96 $54,117 - $69,048	6,300 New	6,300 $54,000
Q3 2018 Nov 13, 2018	SELL	$14.31 - $17.65 $39,767 - $49,049	-2,779 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$11.83 - $16.2 $32,875 - $45,019	2,779 New	2,779 $53,000

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $527M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.